A Archambault

405 total citations
18 papers, 330 citations indexed

About

A Archambault is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, A Archambault has authored 18 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Gastroenterology and 4 papers in Epidemiology. Recurrent topics in A Archambault's work include Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (4 papers) and Gastrointestinal motility and disorders (4 papers). A Archambault is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (4 papers) and Gastrointestinal motility and disorders (4 papers). A Archambault collaborates with scholars based in Canada, France and United States. A Archambault's co-authors include P Padieu, Philippe Gambert, B.F. Maume, Christian Lallemant, Gary R. Lichtenstein, William J. Sandborn, J. P. Baker, Patricia K. Heath, Fabio Cominelli and Brian G. Feagan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Chromatography A.

In The Last Decade

A Archambault

18 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Archambault Canada 9 193 104 90 76 46 18 330
ABR Thomson Canada 11 282 1.5× 201 1.9× 38 0.4× 39 0.5× 48 1.0× 44 419
Nuray Uslu Türkiye 11 132 0.7× 117 1.1× 64 0.7× 70 0.9× 25 0.5× 22 298
Takuji Fujisawa Japan 13 352 1.8× 138 1.3× 30 0.3× 115 1.5× 56 1.2× 23 559
D Kleczkowski Sweden 6 230 1.2× 143 1.4× 128 1.4× 85 1.1× 54 1.2× 8 454
Bilal Ergül Türkiye 10 174 0.9× 73 0.7× 32 0.4× 82 1.1× 50 1.1× 37 315
Zeynal Doğan Türkiye 10 153 0.8× 62 0.6× 23 0.3× 70 0.9× 33 0.7× 27 268
G Schmidt Australia 9 336 1.7× 168 1.6× 57 0.6× 75 1.0× 69 1.5× 18 439
A Zifroni United States 6 133 0.7× 32 0.3× 91 1.0× 264 3.5× 20 0.4× 7 458
Kui Chun Lam Hong Kong 8 174 0.9× 100 1.0× 22 0.2× 232 3.1× 32 0.7× 10 527
S. E. Miederer Germany 11 204 1.1× 68 0.7× 18 0.2× 26 0.3× 82 1.8× 50 324

Countries citing papers authored by A Archambault

Since Specialization
Citations

This map shows the geographic impact of A Archambault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Archambault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Archambault more than expected).

Fields of papers citing papers by A Archambault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Archambault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Archambault. The network helps show where A Archambault may publish in the future.

Co-authorship network of co-authors of A Archambault

This figure shows the co-authorship network connecting the top 25 collaborators of A Archambault. A scholar is included among the top collaborators of A Archambault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Archambault. A Archambault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Feagan, Brian G., William J. Sandborn, J. P. Baker, et al.. (2005). A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease. Alimentary Pharmacology & Therapeutics. 21(4). 373–384. 26 indexed citations
2.
Archambault, A. (2001). Vascular endothelial growth factor production by isolated rat hepatocytes after cold ischemia—warm reoxygenation. Liver Transplantation. 7(11). 988–997. 8 indexed citations
3.
Feagan, Brian G., Stephen B. Hanauer, Fabio Cominelli, et al.. (2000). A six-month open label assessment of steroid sparing properties of CDP571, a humanized antibody to TNFA in steroid dependent patients with Crohn's disease. Gastroenterology. 118(4). A1340–A1340. 1 indexed citations
5.
Lauritsen, K., G. Brunner, Sven V. Eriksson, et al.. (1999). Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease. SHILAP Revista de lepidopterología. 13(10). 806–813. 3 indexed citations
6.
Zanten, Sander Veldhuyzen van, Alain Farley, Norman E. Marcon, et al.. (1998). Efficacy of colloidal bismuth subcitrate, metronidazole, and tetracycline HCl in eradication of H. pylori: A randomized, placebo-controlled study. Gastroenterology. 114. A322–A322. 1 indexed citations
7.
Thomson, ABR, et al.. (1997). A Double‐Blind Randomized Study of Cisapride in the Treatment of Nonulcer Dyspepsia. Canadian Journal of Gastroenterology and Hepatology. 11(2). 127–134. 45 indexed citations
8.
Wurzer, H, Luı́s Rodrigo, David Stamler, et al.. (1997). Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcer. Alimentary Pharmacology & Therapeutics. 11(5). 943–952. 73 indexed citations
9.
Beauchamp, Gilles, et al.. (1991). Surgical treatment of achalasia in a general hospital.. PubMed. 34(5). 487–90. 1 indexed citations
10.
Archambault, A, et al.. (1990). The Equivalence of Two Open Therapeutic Regimens of Cimetidine in the Treatment of Acute Duodenal Ulcer Disease: A Canadian Multicentre Trial. SHILAP Revista de lepidopterología. 4(2). 54–58. 2 indexed citations
11.
Farley, Alain, Dominique Lévesque, Pierre Paré, et al.. (1985). A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.. PubMed. 80(9). 665–8. 16 indexed citations
12.
Archambault, A, et al.. (1984). Chromatography of C18, C19 and C21 sterods on Sephadex LH-20. Journal of Chromatography A. 284. 261–268. 4 indexed citations
13.
Leroux, Philippe, Alain Farley, A Archambault, et al.. (1983). Effect of ranitidine on healing of peptic ulcer: a 2-month study.. PubMed. 78(4). 227–30. 9 indexed citations
14.
Beauchamp, Gilles, et al.. (1981). Death and complications after total colectomy for inflammatory bowel disease.. PubMed. 24(5). 463–6, 484. 5 indexed citations
15.
Girard, R., et al.. (1981). Hereditary pancreatitis: report of an affected Canadian kindred and review of the disease.. PubMed Central. 125(6). 576–80. 10 indexed citations
16.
Gambert, Philippe, Christian Lallemant, A Archambault, B.F. Maume, & P Padieu. (1979). Assessment of serum cholesterol by two methods: Gas—liquid chromatography on a capillary column and chemical ionization-mass fragmentography with isotopic dilution of [3,4-13C]cholesterol as internal standard. Journal of Chromatography B Biomedical Sciences and Applications. 162(1). 1–6. 60 indexed citations
17.
Gillies, Richard, et al.. (1978). Controlled comparison of two dosage regimens of cimetidine in duodenal ulcer. Gastroenterology. 74(2). 396–396. 7 indexed citations
18.
Archambault, A, et al.. (1977). Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study.. PubMed. 117(10). 1155–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026